ARTICLE SUMMARY:
Sustained COVID-19 pressures continue to put IVDs in the spotlight—lab diagnostics were the most common topic of focus in February among global policy documents captured in Pathways’ Document Depot. A look at those docs and some other important releases from last month.
Docs of the Month is a regular column highlighting key findings from Pathways’ Document Depot, a running inventory of global medtech regulatory and policy official documents, including rules, guidance documents, memos, white papers, and more from national authorities, non-governmental groups, and global organizations.
February was a relatively light month for medtech policy documents, but among those that were issued around the globe, IVDs were a prevalent subject. Of the 26 documents captured in Pathways’ Document Depot in February, six of them address IVD policies. Five of those directly target COVID-19 test policies, underscoring that, one year into the global pandemic, governments continue to wrestle with policies to support effective testing programs.
